Conditions: Diabetes Diabetes Mellitus, Type 1
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1290
Healthy volunteers: no

Brief summary:
This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of FIAsp (faster-acting insulin aspart) compared to insulin aspart, both in combination with insulin detemir in adults with type 1 diabetes. This trial consists of two periods: a 26 week treatment period followed by a 26 week additional treatment period.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: Faster-acting insulin aspart intervention 2: insulin detemir intervention 3: insulin aspart intervention 4: Faster-acting insulin aspart
Intervention descriptions: intervention 1: Injected subcutaneously (s.c., under the skin), dose individually adjusted. Meal time dosing is defined as injecting 0-2 minutes before the meal. intervention 2: Injected subcutaneously (s.c., under the skin), dose individually adjusted. Administrated once or twice daily. intervention 3: Injected subcutaneously (s.c., under the skin), dose individually adjusted. intervention 4: Injected subcutaneously (s.c., under the skin), dose individually adjusted. Post meal time dosing is defined as injecting 20 minutes after the start of the meal.

Protocol document: